106 results
8-K
EX-10.3
PSTX
Poseida Therapeutics Inc
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
anniversary of the specified vesting commencement date.
2.3 Expense Reimbursement. The Company will reimburse Executive for reasonable business … expenses in accordance with the Company’s standard expense reimbursement policy, as the same may be modified by the Company from time to time
8-K
EX-10.1
702 o0g5kutc73wov2a
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.2
1mikee dj2
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-1.1
p0f6y9949sy 9yu9w
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm
424B5
7n2dbo4 xm8tal3iskt
4 Aug 22
Prospectus supplement for primary offering
4:52pm
424B5
hjg81j8onh2m 8hr180
3 Aug 22
Prospectus supplement for primary offering
4:05pm
8-K
z7uzbn9
3 Aug 22
Poseida Therapeutics Announces Strategic Global
7:36am